Picture of Xtant Medical Holdings logo

XTNT Xtant Medical Holdings Share Price

0.000.00%
us flag iconLast trade - 00:00
HealthcareAdventurousSmall CapNeutral

Momentum

Relative Strength (%)
1m-7.41%
3m-38.62%
6m-40.41%
1yr-11.97%
Volume Change (%)
10d/3m-42.64%
Price vs... (%)
52w High-48.21%
50d MA-6.7%
200d MA-28.97%

Growth & Value

Shareholder Activity

TypeBuy / Hold / Sell
Institutions
Directors
Community

Guru Screens

Quality

NameIndustryMarket
Return on Capital-0.55%
Return on Equity-4.13%
Operating Margin-0.35%

Financial Summary

Health Trend(F-Score)

12345678910

Bankruptcy Score(Z-Score)

Distress
Cautious
Safe

Earnings Manipulation Risk(M-Score)

Other Ratios

Leverage (ttm)Total- Intang+ Pension
Gross Gearing
Net Gearing
Cash / Assets

Recent History

Latest interim period vs. prior periodIndustryMarket
Sales Growth
EPS Growth
3yr Compound Annual Growth RateIndustryMarket
Sales CAGR
EPS CAGR
DPS CAGR

Graphical History

Revenue
Blurred out image of Revenue chart
Net Income
Blurred out image of Net Income chart
Normalised EPS
Blurred out image of Normalised EPS chart
PE Ratio Range
Blurred out image of PE Ratio Range chart
Dividend Yield Range
Blurred out image of Dividend Yield Range chart

Analyst Forecasts

Price target
( price)
31st Dec 202431st Dec 2025
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change

Analyst Consensus

Strong SellSellHoldBuyStrong Buy

EPS 2024 / 2025

Blurred out image of Xtant Medical Holdings EPS forecast chart

Profile Summary

Xtant Medical Holdings, Inc. is a global medical technology company. The Company is focused on the design, development, and commercialization of a comprehensive portfolio of orthobiologics and spinal implant fixation systems to facilitate spinal fusion in complex spine, deformity, and degenerative procedures. Its products are used by orthopedic spine surgeons and neurosurgeons to treat a variety of spinal disorders in the cervical, thoracolumbar, and interbody spine. Its biomaterial products include OsteoSponge, OsteoSponge SC, OsteoSelect DBM putty, OsteoSelect Plus DBM putty, OsteoWrap, and its line of 3Demin products, as well as other allografts. It offers a comprehensive line of products that are used to treat a variety of spinal and sacroiliac conditions, including trauma, degeneration, deformity and tumor. Its key spinal implant product lines include Cervical Products, Thoracolumbar Products, Sacroiliac Joint Products, Interbody Products and Interlaminar Stabilization Products.

Directors

Last Annual
December 31st, 2023
Last Interim
March 31st, 2024
Incorporated
August 8th, 2006
Public Since
June 30th, 2010
No. of Shareholders
166
No. of Employees
207
Sector
Healthcare Equipment & Supplies
Industry
Healthcare
Exchange
us flag iconNYSE MKT
Shares in Issue
130,268,590

XTNT Share Price Performance

Upcoming Events for XTNT

Xtant Medical Holdings Inc Annual Shareholders Meeting

Xtant Medical Holdings Inc Annual Shareholders Meeting

Q2 2024 Xtant Medical Holdings Inc Earnings Release

Q3 2024 Xtant Medical Holdings Inc Earnings Release

Similar to XTNT

FAQ